Building Korro Bio: A CEO’s Perspective on Innovation and Risk Management

by Biotech Newsroom


By Ram Aiyar, CEO of Korro Bio, as part of the From The Trenches feature of LifeSciVC

It has been an extraordinary journey so far and one that continues to humble, inspire and motivate me every day. I’ve had the honor and responsibility of building a visi on that is ambitious while being grounded in scientific rigor. Over the last 4.5 years, Korro has been built by mitigating one layer of risk at a time. This has culminated in a strong team, a robust pipeline, a set of supportive investors, board members, and key opinion leaders.

2025 holds to be a transformative year for us, with the potential for multiple milestones to come to fruition,…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC